PULMATRIX, INC. Payments of Stock Issuance Costs
PULMATRIX, INC. (PULM) reported Payments of Stock Issuance Costs of $163.00 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2015-06-10
- PULMATRIX, INC. payments of stock issuance costs for the quarter ending 2015-03-31 was $0.00.
- PULMATRIX, INC. payments of stock issuance costs for the quarter ending 2014-12-31 was $0.00.
- PULMATRIX, INC. payments of stock issuance costs for the quarter ending 2014-09-30 was $0.00.
- PULMATRIX, INC. payments of stock issuance costs for the quarter ending 2014-06-30 was $163.00K.
- PULMATRIX, INC. payments of stock issuance costs for fiscal 2015 was $163.00K, a 20.87% decline from fiscal 2014.
- PULMATRIX, INC. payments of stock issuance costs for fiscal 2014 was $206.00K, a 368.18% increase from fiscal 2013.
- PULMATRIX, INC. payments of stock issuance costs for fiscal 2013 was $44.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $0.00 derived: sum of 2 quarters · filed 2015-06-10 | $0.00 derived: sum of 3 quarters · filed 2015-06-10 | $163.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $163.00K 10-Q · filed 2015-02-13 | |
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $163.00K 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | $163.00K 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | $206.00K 10-K · filed 2015-06-10 | |||
| 2013-03-31 | $44.00K 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |